Skip to main content
Seth Walker, MD, Pulmonology, Atlanta, GA

SethDWalkerMD

Pulmonology • Atlanta, GA

Asthma & COPD, Critical Care Medicine, Cystic Fibrosis, Infectious Disease

Staff physician, Piedmont Pulmonary and Critical Care Medicine

Join to view full profile

Dr. Walker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Walker's full profile

Already have an account?

  • Office

    275 Collier Rd NW
    Suite 300
    Atlanta, GA 30309
    Phone+1 404-350-0009

Education & Training

  • University of Rochester
    University of RochesterFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine/Pediatrics, 2001 - 2005
  • West Virginia University School of Medicine
    West Virginia University School of MedicineClass of 2001

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2018 - Present
  • GA State Medical License
    GA State Medical License 2011 - 2025
  • WV State Medical License
    WV State Medical License 2008 - 2011
  • NY State Medical License
    NY State Medical License 2006 - 2008
  • VA State Medical License
    VA State Medical License 2001 - 2005
  • American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

Journal Articles

  • Tidal breathing responses to albuterol and normal saline in infants with viral bronchiolitis  
    (1) Scarlett EE, Walker S, Rovitelli A, and Ren CL, Pediatric Allergy, Immunology, and Pulmonology, 12/1/2012
  • Refusal of Venous Thromboembolism Prophylaxis and Incidence of Thrombosis in Patients with Cystic Fibrosis  
    Taryn S. Murray, PharmD, BCPS; Nicole L. Metzger, PharmD, BCPS; Melissa M. Chesson, PharmD, BCPS; Seth D. Walker, MD, PULMONARY RESEARCH AND RESPIRATORY MEDICINE – OPEN JOURNAL, 12/28/2017
  • When will the Tobacco Control Act be considered a failure?  
    Walker SD, Austin J Pulm Respir Med, 2014

Authored Content

  • Cystic Fibrosis: Disease Manifestations and Current Therapies1/3/2017

Press Mentions

  • An Open-Label Extension Study of Ivacaftor in Children with CF and a CFTR Gating Mutation Initiating Treatment at Age 2-5 Years (KLIMB)
    An Open-Label Extension Study of Ivacaftor in Children with CF and a CFTR Gating Mutation Initiating Treatment at Age 2-5 Years (KLIMB)November 1st, 2019
  • FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR Mutations
    FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR MutationsJune 25th, 2019
  • Symdeko Approved to Treat Younger Cystic Fibrosis Patients
    Symdeko Approved to Treat Younger Cystic Fibrosis PatientsJune 24th, 2019
  • Join now to see all

Professional Memberships

Dr. Seth Walker, Dr. Seth Walker, MD, Dr. S Walker, Dr. Seth D Walker